JPRN-jRCT1040220153招募中2 期
A randomized controlled phase 2 trial comparing the safety and usefulness of robot-assisted esophagectomy and thoracoscopic - ROBOCOP
Takeuchi Hiroya0 个研究点目标入组 90 人开始时间: 2023年2月28日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Intended for patients who meet all of the following criteria
- •1.Patients over 18 years old
- •2. Patients diagnosed with esophageal or gastroesophageal junction cancer
- •3. Patients scheduled for subtotal thoracic esophagectomy with bilateral recurrent laryngeal perineural lymph node (#106recR and #106recL) dissection
- •4. Those who have obtained consent to participate in this research by signing a consent form by themselves or their proxy
排除标准
- •Patients who meet any of the following conditions will not be included in this study.
- •1. Subjects with recurrent laryngeal nerve palsy before surgery
- •2. Patients with heart disease (NYHA III-IV, severe arrhythmia)
- •3. Subjects with severe liver disorder (fulminant hepatitis, hepatic encephalopathy, Child-Pugh classification Grade C)
- •4. Subjects with severe renal impairment (chronic kidney disease stage 4 or 5 according to CKD guidelines)
- •5. Women who are pregnant or may become pregnant
- •6. breastfeeding woman
- •7. Subjects with dementia
- •8. Those judged inappropriate by the investigator
研究者
相似试验
已完成
2 期
A phase II randomized controlled trial comparing perioperative mFOLFOXIRI with perioperative chemoradiotherapy for locally advanced rectal cancer.Rectal cancerJPRN-UMIN000018624Osaka Medical College Hospital34
尚未招募
2 期
A phase II Randomized controlled trial A comparison of short-course radiation and chemotherapy with or without intraperitoneal paclitaxel for locally advanced, non-metastatic signet-ring cell rectal cancersCTRI/2024/04/065785Tata Memorial Centre
尚未招募
2 期
A clinical trial comparing pulmonary complications in two routes of gastric conduit placement after esophagectomyCTRI/2024/02/062245AIIMS NEW DELHI
进行中（未招募）
1 期
A randomized comparative phase II trial evaluating the capacity of the dualcombination doravirine/raltegravir to maintain virological success in HIV-1infected patients with an HIV-RNA plasma viremia below 50 copies/mL under acurrent antiretroviral regimen.HIV-1 INFECTIONEUCTR2019-004195-19-ITCentre de Recherche et d’Etudes sur la Pathologie Tropical et le Sida (CREPATS)150
进行中（未招募）
1 期
A randomized comparative phase II trial evaluating the capacity of the dual combination doravirine/raltegravir to maintain virological success in HIV-1 infected patients with an HIV-RNA plasma viremia below 50 copies/mL under a current antiretroviral regimeEUCTR2019-004195-19-FRCentre de Recherche et d’Etudes sur la Pathologie Tropicale et le Sida (CREPATS)150